Induction of intestinal multidrug resistance-associated protein 2 (Mrp2) by spironolactone in rats

European Journal of Pharmacology

Volumn 623, Issue 1-3, 2009, Pages 103-106

  Ruiz, María L ^a   Villanueva, Silvina S M ^a   Luquita, Marcelo G ^a   Pellegrino, José M ^a   Rigalli, Juan P ^a   Arias, Agostina ^a   Sánchez Pozzi, Enrique J ^a   Mottino, Aldo D ^a   Catania, Viviana A ^a  

^a UNIVERSIDAD NACIONAL DE ROSARIO   (Argentina)

Author keywords

Intestinal transport; Multidrug resistance associated protein 2 (Mrp2); Spironolactone

Indexed keywords

DINITROPHENYL S GLUTATHIONE; GLUTATHIONE DERIVATIVE; KETOCONAZOLE; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN 2; SPIRONOLACTONE; UNCLASSIFIED DRUG;

ADULT ANIMAL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; IMMUNOFLUORESCENCE; JEJUNUM; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; RAT; REAL TIME POLYMERASE CHAIN REACTION; SMALL INTESTINE; TISSUE DISTRIBUTION; TRANSCRIPTION REGULATION; UPREGULATION; WESTERN BLOTTING;

ANIMALS; BIOLOGICAL TRANSPORT; CELL POLARITY; DINITROCHLOROBENZENE; GENE EXPRESSION REGULATION; GLUTATHIONE; INTESTINE, SMALL; MALE; MICROVILLI; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; ORGAN SPECIFICITY; POLYMERASE CHAIN REACTION; RATS; RATS, WISTAR; RECEPTORS, STEROID; RNA, MESSENGER; SPIRONOLACTONE;

EID: 70350211426     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2009.09.014     Document Type: Article

References (21)

1. Arias A., Villanueva S.S., Ruiz M.L., Luquita M.G., Veggi L.M., Pellegrino J.M., Vore M., Catania V.A., and Mottino A.D. Regulation of expression and activity of rat intestinal multidrug resistance-associated protein 2 by cholestatic estrogens. Drug Metab. Dispos. 37 6 (2009) 1277-1285
2. Bock K.W., Eckle T., Ouzzine M., and Fournel-Gigleux S. Coordinate induction by antioxidants of UDP-glucuronosyltransferase UGT11A6 and the apical conjugate export pump MRP2 (multidrug resistance protein 2) in Caco-2 cells. Biochem. Pharmacol. 59 (2000) 467-470
3. Catania V.A., Luquita M.G., Sánchez Pozzi E.J., and Mottino A.D. Differential induction of glutathione S-transferase subunits by spironolactone in rat liver, jejunum and colon. Life Sci. 63 (1998) 2285-2293
4. Chiba M., Itagaki S., Kobayashi M., Hirano T., and Iseki K. Down-regulation ofintestinal multidrug resistance-associated protein 2 in long-evans cinnamon rats. Drug Metab. Pharmacokinet. 22 6 (2007) 450-455
5. Dietrich C.G., Geier A., Salein N., Lammert F., Roeb E., Oude Elferink R.P., Matern S., and Gartung G. Consequences of bile duct obstruction on intestinal expression and function of multidrug resistance-associated protein 2. Gastroenterology 126 (2004) 1044-1053
6. Huang H., Wang H., Sinz M., Zoeckler M., Staudinger J., Redinbo M.R., Teotico D.G., Locker J., Kalpana G.V., and Mani S. Inhibition of drug metabolism by blocking the activation of nuclear receptors by ketoconazole. Oncogene 26 (2007) 258-268
7. Johnson D.R., and Klaassen C.D. Regulation of rat multidrug resistance protein 2 by classes of prototypical microsomal enzyme inducers that activate distinct transcription pathways. Toxicol. Sci. 67 (2002) 182-189
8. Kast H.R., Goodwin B., Tarr P.T., Jones S.A., Anisfeld A.M., Stoltz C.M., Tontonoz P., Kliewer S., Willson T.M., and Edwards P.A. Regulation of multidrug resistance-associated protein 2 (ABCC2) by the nuclear receptors pregnane X receptor, farnesoid X-activated receptor, and constitutive androstane receptor. J. Biol. Chem. 277 (2002) 2908-2915
9. König J., Nies A.T., Cui Y., Leier I., and Keppler D. Conjugate export pumps of the multidrug resistance protein (MRP) family: localization, substrate specificity, and MRP2-mediated drug resistance. Biochem. Biophys. Acta 1461 (1999) 377-394
10. Miguet J.P., Vuitton D., Thebault-Lucas A., Joanne C., and Dhumeaux D. Spironolactone and enzyme induction in patients with alcoholic cirrhosis. Gastroenterology 78 (1980) 996-1000
11. Mottino A.D., Hoffman T., Jennes L., and Vore M. Expression and localization of multidrug resistant protein Mrp2 in rat small intestine. J. Pharmacol. Exp. Ther. 293 (2000) 717-723
12. Mottino A.D., Hoffman T., Jennes L., Cao J., and Vore M. Expression of multidrug resistance-associated protein 2 in small intestine from pregnant and postpartum rats. Am. J. Physiol.: Gasterointest. Liver Physiol. 280 (2001) G1261-G1273
13. Naud J., Michaud J., Boisvert C., Desbiens K., Leblond F.A., Mitchell A., Jones C., Bonnardeaux A., and Pichette V. Down-regulation of intestinal drug transporters in chronic renal failure in rats. J. Pharmacol. Exp. Ther. 320 3 (2007) 978-985
14. Ruiz M.L., Villanueva S.S.M., Luquita M.G., Sánchez Pozzi E.J., Crocenzi F.A., Pellegrino J.M., Ochoa J.E., Vore M., Mottino A.D., and Catania V.A. Mechanisms involved in spironolactone-induced choleresis in the rat. Role of multidrug resistance-associated protein 2. Biochem. Pharmacol. 69 (2005) 531-539
15. Ruiz M.L., Villanueva S.S.M., Luquita M.G., Ikushiro S.I., Mottino A.D., and Catania V.A. Beneficial effect of spironolactone administration in EE-induced cholestasis in the rat. Involvement of up-regulation of Mrp2. Drug Metab. Dispos. 35 (2007) 2060-2066
16. Schuetz E.G., Brimer C., and Schuetz J.D. Environmental xenobiotics and the antihormone cyproterone acetate and spironolactone use the nuclear hormone pregnenolone X receptor to activate the Cyp3A23 hormone response element. Mol. Pharmacol. 54 (1998) 1113-1117
17. Sokolovsky M., Sadeh T., and Patchornik A. Nonenzymatic cleavages of peptide chains at the cysteine and serine residues through their conversion to dehydroalanine (DHAL). II. The specific chemical cleavage of cysteinyl peptides. J. Am. Chem. Soc. 86 (1964) 1210-1217
18. Takano M., Yumoto R., and Murakami T. Expression and function of efflux drug transporters in the intestine. Pharmacol. Ther. 109 (2006) 137-161
19. Villanueva S.S.M., Ruiz M.L., Luquita M.G., Sánchez Pozzi E.J., Catania V.A., and Mottino A.D. Involvement of Mrp2 in hepatic and intestinal disposition of dinitrophenyl-S-glutathione in partially hepatectomized rats. Toxicol. Sci. 84 (2005) 4-11
20. Wirth K.E., Frolich J.C., Hollifield J.W., Falkner F.C., Sweetman B.S., and Oates J.A. Metabolism of digitoxin in man and its modification by spironolactone. Eur. J. Clin. Pharmacol. 09 (1976) 345-354
21. Xu C., Li C.Y., and Kong A.N. Induction of phase I, II and III drug metabolism/transport by xenobiotics. Arch. Pharm. Res. 28 (2005) 249-268